PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25926F0264Emergency pharmacy carvykti for RMR — Janssen Biotech Inc

Janssen Biotech Inc holds $1.5M across 46 federal awards, concentrated at Department of Veterans Affairs (VA). The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Aug 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

Network Contract Office 19 (36C259)

Awarding office

Janssen Biotech Inc

Recipient

Aug 31, 2026

PoP end

$385K

Obligated

$385K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Janssen Biotech Inc — $90

Contract facts

Federal

Contract number36C25926F0264

Also listed as36C259-26-F-0264

Also listed as36F79724D0176-36C25926F0264

AgencyNetwork Contract Office 19 (36C259)

Awarding officeNetwork Contract Office 19 (36C259)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentJanssen Biotech Inc

CAGE0MJM1

UEINVYMGFA53MN7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79724D0176

Place of performanceHORSHAM PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJul 31, 2026

PoP end (current)Aug 31, 2026

Obligated$385K

Current value$385K

Potential value$385K

EMERGENCY PHARMACY CARVYKTI FOR RMR is a federal award for Network Contract Office 19 (36C259) held by Janssen Biotech Inc. Estimated value $385K ($385K obligated). Current period of performance ends Aug 31, 2026. Last award drew 1 bidder. Place of performance: HORSHAM PA.

Recompete timing

Public

● Expiring in 10 days

Current PoP ends Aug 31, 2026 (10 days remaining). Agencies typically plan 12–18 months ahead — at 0.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Janssen Biotech Inc — $1.5M obligated across 46 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$1.5M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25926F0264?

36C25926F0264 (Emergency pharmacy carvykti for RMR) is a Network Contract Office 19 (36C259) award with a potential value of $385K, currently held by Janssen Biotech Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C259-26-F-0264?

36C259-26-F-0264 is the dashed form of PIID 36C25926F0264 (Emergency pharmacy carvykti for RMR), held by Janssen Biotech Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25926F0264?

Network Contract Office 19 (36C259) awarded 36C25926F0264 to Janssen Biotech Inc (potential $385K).

Who is the incumbent on 36C25926F0264?

Janssen Biotech Inc is the incumbent with $1.5M across 46 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.

When does Janssen Biotech Inc’s 36C25926F0264 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 11, 2026 · refreshed monthlyLatest procurement action Jul 30, 2026